James Atkins to Esophageal Neoplasms
This is a "connection" page, showing publications James Atkins has written about Esophageal Neoplasms.
Connection Strength
0.066
-
Williamson SK, McCoy SA, Gandara DR, Dakhil SR, Yost KJ, Paradelo JC, Atkins JN, Blanke CD, Abbruzzese JL. Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial. Am J Clin Oncol. 2006 Apr; 29(2):116-22.
Score: 0.066